4.6 Article

Bayesian and influence function-based empirical likelihoods for inference of sensitivity in diagnostic tests

期刊

STATISTICAL METHODS IN MEDICAL RESEARCH
卷 29, 期 12, 页码 3457-3491

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0962280220929042

关键词

Bayesian inference; confidence intervals; empirical likelihood; influence function; sensitivity

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI (Department of Defense) [W81XWH-122-0012]
  3. National Institute on Aging
  4. National Institute of Biomedical Imaging and Bioengineering
  5. Alzheimers Association
  6. Alzheimers Drug Discovery Foundation
  7. Araclon Biotech
  8. Biogen
  9. Bristol-Myers Squibb Company
  10. CereSpir, Inc.
  11. Cogstate
  12. Elan Pharmaceuticals, Inc.
  13. Eli Lilly and Company
  14. EuroImmun
  15. F. Hoffmann-La Roche Ltd
  16. Canadian Institutes of Health Research
  17. ADNI clinical sites in Canada
  18. AbbVie
  19. BioClinica, Inc.
  20. Eisai Inc.

向作者/读者索取更多资源

In medical diagnostic studies, a diagnostic test can be evaluated based on its sensitivity under a desired specificity. Existing methods for inference on sensitivity include normal approximation-based approaches and empirical likelihood (EL)-based approaches. These methods generally have poor performance when the specificity is high, and some require choosing smoothing parameters. We propose a new influence function-based empirical likelihood method and Bayesian empirical likelihood methods to overcome such problems. Numerical studies are performed to compare the finite sample performance of the proposed approaches with existing methods. The proposed methods are shown to perform better in terms of both coverage probability and interval length. A real data set from Alzheimer's Disease Neuroimaging Initiative (ANDI) is analyzed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据